share_log

Stocks of the Hour: Vintage Energy, Rumble Resources, QX Resources, Dimerix, BluGlass

Stocks of the Hour: Vintage Energy, Rumble Resources, QX Resources, Dimerix, BluGlass

熱門股票:Vintage Energy、Rumble Resources、QX Resources、Dimerix、Blu
sharecafe ·  2023/10/04 20:43

Vintage Energy (ASX:VEN) announces an additional two-year gas sale under the master gas supply agreement for the Odin gas field. The joint venture parties have agreed and signed terms with Pelican Point Power for the supply of gas from 1 January 2025 to 31 December 2026. Shares are trading flat at 2.7 cents.

Vintage Energy(澳大利亞證券交易所股票代碼:VEN)宣佈,根據Odin氣田的主天然氣供應協定,將再出售為期兩年的天然氣。合資各方已與鵜鶘Point Power就2025年1月1日至2026年12月31日的天然氣供應達成協定並簽署了條款。股票交易持平於2.7美分。

Rumble Resources (ASX:RTR) has announced that high grade zinc and lead has been intersected at the Earaheedy Project. The width and tenor of mineralisation intercepted indicates that potential feeder faults exist at the Project and confirms the prospectivity of the 9km x 3km area to host high grade Zn-Pb sulphide mineralisation. Shares are trading 4.76 per cent higher at 11 cents.

朗博資源公司(澳大利亞證券交易所股票代碼:RTR)宣佈,高品位鋅和鉛已在Earahedy專案中相交。截獲的礦化寬度和主旨顯示,該專案存在潛在的饋送斷層,並證實了9公里×3公里區域內蘊藏高品位鋅鉛硫化物礦化的前景。該公司股價上漲4.76%,至11美分。

QX Resources (ASX:QXR) has signed a formal documentation to acquire a 75% Interest in the 100km2 Liberty Lithium Brine Project in the USA. In response, QXR Managing Director, Stephen Promnitz, said: "The Liberty Lithium Project is potentially a new large-scale lithium brine project - in the right location, with good infrastructure and a pathway to development." Shares are on a trading halt and last traded at 2.3 cents.

QX Resources(澳大利亞證券交易所股票代碼:QXR)簽署了一份正式檔案,將收購美國100平方公里Liberty鋰鹵水專案75%的權益。對此,董事董事總經理史蒂芬·普羅姆尼茨表示:“自由鋰專案有可能是一個新的大型鹵水鋰專案--地理位置優越,基礎設施完善,發展道路廣闊。”股票暫停交易,最後交易價格為2.3美分。

Dimerix (ASX:DXB) and ADVANZ PHARMA have entered into an exclusive licence agreement for the UK, Switzerland, Canada, Australia, and New Zealand for the commercialisation of Dimerix' Phase 3 drug candidate DMX-200 for the treatment of FSGS, which is a rare type of kidney disease. Dimerix will receive up to ~AU$230* million in upfront and milestone payments, plus royalties. Shares are trading 88.52 per cent higher at 11.5 cents.

迪梅裡克斯公司(澳大利亞證券交易所代碼:DXB)和ADVANZ Pharma公司已經達成了一項英國、瑞士、加拿大、澳大利亞和紐西蘭的獨家許可協定,將迪梅裡克斯的第三階段候選藥物DMX-200商業化,用於治療FSGS,這是一種罕見的腎臟疾病。Dimerix將獲得高達2.3億澳元的預付款和里程碑付款,外加特許權使用費。該公司股價上漲88.52%,至11.5美分。

BluGlass Limited (ASX:BLG) has been named a member of the Commercial Leap Ahead for Wide-bandgap Semiconductors (CLAWS) Hub, one of eight Microelectronics Commons regional innovation hubs announced by the US Department of Defense. This is a part of the US$238M funding initiative in FY23 to establish these hubs, aimed at boosting America's capabilities in cutting-edge microelectronics development and production. Shares are trading 13.51 per cent higher at 4.2 cents.

BluGlass Limited(澳大利亞證券交易所股票代碼:BLG)被任命為寬禁帶半導體(爪子)商業躍進中心的成員,該中心是美國國防部宣佈的八個微電子共用地區創新中心之一。這是23財年2.38億美元資金計劃的一部分,目的是建立這些中心,旨在提升美國在尖端微電子開發和生產方面的能力。該公司股價上漲13.51%,至4.2美分。

1x1.png?futu_img_keep_extra_domain=1

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論